Baseline interleukin‐10 levels as a predictive biomarker for achieving clinical response with abatacept in disease‐modifying antirheumatic drug‐naive and anticitrullinated protein antibody‐positive patients with early rheumatoid arthritis
Objective Predictive biomarkers for patients with early rheumatoid arthritis (RA) are needed. This exploratory post hoc analysis investigated inflammatory biomarkers associated with baseline disease activity and biomarkers predictive of treatment response in patients who were se…